close

Enter

Log in using OpenID

Fibromyalgia Treatment Market

embed
Fibromyalgia is a common and complex chronic pain disorder that causes musculoskeletal pain, fatigue, and localized tenderness affecting individuals mentally, physically, and socially.
Fibromyalgia Treatment Market – Size, Share,
Outlook, and Opportunity Analysis, 2018 – 2026
Fibromyalgia is a common and complex chronic pain disorder that causes musculoskeletal pain,
fatigue, and localized tenderness affecting individuals mentally, physically, and socially.
Fibromyalgia is mainly caused due to genetic conditions, however actual cause is still unknown.
The most common symptoms of fibromyalgia are fatigue, sleeping problems, chronic muscle
pain, and tender points. An individual with fibromyalgia can also have symptoms such as
headaches, poor concentration, and depression. Fibromyalgia symptoms might accumulate with
time or it can be caused by some external factors. Fibromyalgia treatments include therapy,
medications, regular aerobic exercise, stress reduction, and others. Furthermore, for treatment of
fibromyalgia, antidepressants or pain medications are prescribed to treat depression, anxiety,
pain, and fatigue.
Request Sample Copy of Research Report @
https://www.coherentmarketinsights.com/insight/request-sample/1691
Robust pipeline of novel drugs are under late clinical trial phase for treatment of fibromyalgia
Market players are focusing on active research and development, in order to introduce new
products in the market and increase treatment options. Approval and launch of novel
fibromyalgia treatment drugs is expected to significantly support fibromyalgia treatment market
growth over the forecast period.
For instance, manufacturers such as Aptinyx, Inc., Prismic Pharmaceuticals, Inc., Innovative
Med Concepts, Inc., Intec Pharma Ltd., Astellas Pharma, Inc., and others have drugs in the
pipeline indicated for the treatment of fibromyalgia.
Many such drugs are in phase 2 and phase 3 of clinical trials with commercialization potential.
For instance, Astellas Pharma, Inc. has ASP0819 in phase 2 and IMC-1 that received fast track
designation from the U.S. FDA in 2016.
The global fibromyalgia treatment market size was valued at US$ 2,778.6 Mn in 2018 and is
expected to witness a CAGR of 3.3% during the forecast period (2018 – 2026).
Report includes chapters which deeply display the following deliverable about industry :
• Fibromyalgia Treatment Market Research Objective and Assumption
• Fibromyalgia Treatment Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Fibromyalgia Treatment Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Fibromyalgia Treatment Market, By Regions
• Fibromyalgia Treatment Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Fibromyalgia Treatment Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Fibromyalgia Treatment Market Manufacturing Cost Analysis including Key Raw Materials and
Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Fibromyalgia Treatment Market Forecast including Production, Consumption, Import and
Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Market Dynamics
Key players in the market are focusing on frequent research and development activities for
development of novel medications for fibromyalgia treatment. Launch of novel drugs in the
market for fibromyalgia is expected to boost the fibromyalgia treatment market growth over the
forecast period. For instance, drug candidate IMC-1 is being developed by Innovative Med
Concepts, which received fast track designation from the U.S. FDA in 2016
In December 2018, Aptinyx Inc. announced positive results from an interim analysis of an
exploratory study of its novel NMDA receptor (NMDAr) modulator, NYX-2925, in subjects with
fibromyalgia. Subjects in the study received daily oral doses of NYX-2925 at two dose levels, 20
mg and 200 mg, as well as placebo, over the course of six weeks.
Market Opportunity
Currently, there are limited number of approved treatment options for fibromyalgia. Several
manufacturers have potential candidates in the pipeline (some in late stages as well). Hence,
new players in the market also have opportunity to develop new drug candidate for treatment
of fibromyalgia.
Browse Complete Report For More Information @
https://www.coherentmarketinsights.com/market-insight/fibromyalgia-treatment-market-1691
Another opportunity is present in terms of generic drug manufacturing, as two of the drugs are
expected to lose patent protection over the forecast period (Lyrica in 2019 and Savella in 2021,
2023, and 2029). Patent loss may be a restraint for the market, however, there is certainly an
opportunity for generic manufacturers.
Key players operating in the fibromyalgia treatment market include Eli Lilly and Company,
Pfizer, Inc., Novartis AG, Allergan plc, Sun Pharmaceutical Industries Ltd., Aptinyx, Inc.,
Prismic Pharmaceuticals, Inc., Innovative Med Concepts, Inc., Intec Pharma Ltd., and Astellas
Pharma Inc.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Author
Alex Huge
Alex Huge367   documents Email
Document
Category
Health and Medicine
Views
1
File Size
109 KB
Tags
treatment, Fibromyalgia Treatment Market
1/--pages
Report inappropriate content